Publication | Closed Access

Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis

InflammationHepatologyProlongs SurvivalMedicineLiver PhysiologyLiver CirrhosisPathologyHepatology InflammationHepatotoxicityPharmacotherapyLiver FunctionLiver DiseaseHepatology FibrosisLiverPharmacologyDrug-induced Liver InjuryCirrhosis